Examination of efficacy and safety of new 5-ASA preparation for ulcerative colitis, and new method of evaluating disease condition by measuring fecal concentration of calprotectin.
Phase of Trial: Phase III
Latest Information Update: 24 Dec 2013
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 23 Jun 2011 New trial record